Shares of Transcat, Inc. (NASDAQ:TRNS) have received an average broker rating score of 1.33 (Strong Buy) from the three analysts that cover the stock, Zacks Investment Research reports. One investment analyst has rated the stock with a buy recommendation and two have given a strong buy recommendation to the company.
Brokerages have set a 1-year consensus price objective of $27.67 for the company and are anticipating that the company will post $0.26 EPS for the current quarter, according to Zacks. Zacks has also given Transcat an industry rank of 63 out of 257 based on the ratings given to related companies.
TRNS has been the subject of a number of research analyst reports. Zacks Investment Research cut shares of Transcat from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, October 31st. Singular Research lifted their target price on shares of Transcat from $25.00 to $30.00 and gave the company a “buy” rating in a research note on Tuesday, August 21st.
In related news, Director John T. Smith sold 3,000 shares of the business’s stock in a transaction that occurred on Wednesday, October 31st. The shares were sold at an average price of $10.30, for a total value of $30,900.00. Following the completion of the transaction, the director now owns 42,166 shares in the company, valued at approximately $434,309.80. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders sold a total of 10,639 shares of company stock valued at $109,307 in the last 90 days. 8.80% of the stock is currently owned by corporate insiders.
A number of hedge funds have recently bought and sold shares of the stock. Thomson Horstmann & Bryant Inc. bought a new position in Transcat in the 3rd quarter worth approximately $5,370,000. EAM Investors LLC bought a new position in Transcat in the 3rd quarter worth approximately $737,000. Wasatch Advisors Inc. bought a new position in Transcat in the 3rd quarter worth approximately $5,121,000. O Shaughnessy Asset Management LLC raised its position in Transcat by 11,400.8% in the 3rd quarter. O Shaughnessy Asset Management LLC now owns 14,031 shares of the scientific and technical instruments company’s stock worth $321,000 after purchasing an additional 13,909 shares during the last quarter. Finally, Wedge Capital Management L L P NC raised its position in Transcat by 32.1% in the 3rd quarter. Wedge Capital Management L L P NC now owns 33,021 shares of the scientific and technical instruments company’s stock worth $755,000 after purchasing an additional 8,021 shares during the last quarter. Hedge funds and other institutional investors own 55.17% of the company’s stock.
Shares of NASDAQ:TRNS traded up $0.72 during trading on Friday, reaching $22.31. The stock had a trading volume of 6,371 shares, compared to its average volume of 10,885. Transcat has a 52 week low of $12.20 and a 52 week high of $25.35. The company has a current ratio of 2.00, a quick ratio of 1.33 and a debt-to-equity ratio of 0.42. The stock has a market capitalization of $158.40 million, a P/E ratio of 31.42, a price-to-earnings-growth ratio of 2.76 and a beta of 0.66.
Transcat (NASDAQ:TRNS) last posted its earnings results on Wednesday, October 24th. The scientific and technical instruments company reported $0.20 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.16 by $0.04. Transcat had a net margin of 4.54% and a return on equity of 12.45%. The company had revenue of $38.88 million during the quarter, compared to analysts’ expectations of $38.00 million. As a group, analysts forecast that Transcat will post 1 EPS for the current fiscal year.
Transcat, Inc provides calibration and laboratory instrument services in North America and internationally. It operates in two segments, Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.
Recommended Story: Google Finance
Get a free copy of the Zacks research report on Transcat (TRNS)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.